2025 HCPCS Code G9034
Zanamivir, inhalation powder, administered through inhaler, brand, per 10 mg (for use in a medicare-approved demonstration project)
TAGS: inhalation administered demonstration through| Notice | HCPCS G9034 terminated on December 31, 2019. |
| Short Description | Zanamivir, inh pwdr, brand |
| HCPCS Action Code | N - No maintenance for this code |
| HCPCS Coverage Code | C - Carrier judgment |
| HCPCS Code Added Date | December 01, 2004 |
| HCPCS Action Effective Date | January 01, 2020 |
| HCPCS Pricing Indicator Code | 00 - Service not separately priced by part B (e.G., services not covered, bundled, used by part a only, etc.) |
| HCPCS Type Of Service Code | 1 - Medical care |
| HCPCS Multiple Pricing Indicator Code | 9 - Not applicable as HCPCS not priced separately by part B (pricing indicator is 00) or value is not established (pricing indicator is '99') |
| HCPCS Anesthesia Base Unit Quantity | 0 |
| HCPCS Coverage Issues Manual Reference Section Number |
Check Similar HCPCS Codes
- G0237 - Therapeutic procd strg endur
- G0238 - Oth resp proc, indiv
- G0239 - Oth resp proc, group
- G0245 - Initial foot exam pt lops
- G0246 - Followup eval of foot pt lop
- G0247 - Routine footcare pt w lops
- G0248 - Demonstrate use home inr mon
- G0249 - Provide inr test mater/equip
- G0250 - Md inr test revie inter mgmt
- G0251 - Linear acc based stero radio
- G0252 - Pet imaging initial dx
- G0255 - Current percep threshold tst
- G0257 - Unsched dialysis esrd pt hos
- G0259 - Inject for sacroiliac joint
- G0260 - Inj for sacroiliac jt anesth
- G0268 - Removal of impacted wax md
- G0269 - Occlusive device in vein art
- G0270 - Mnt subs tx for change dx
- G0271 - Group mnt 2 or more 30 mins
- G0276 - Pild/placebo control clin tr